Advances in experimental medicine and biology, v. 214.
یادداشتهای مربوط به مندرجات
متن يادداشت
The Scope of Thromboembolism.- Vitamin K-Dependent Proteins.- The Biochemical Basis of Warfarin Therapy.- Warfarin and the Biochemistry of the Vitamin K Dependent Proteins.- Anticoagulation Proteins C and S.- Warfarin and Bone: Implications for Rational Strategies to Selectively Antagonize the Action of Vitamin K in Target Tissues.- Human Genes for Factor IX and Other Vitamin K Dependent Blood Proteins.- The Prothrombin Time.- Tissue Factor.- INR - Calibration of the Therapeutic Range.- Cold-Promoted Activation of Factor VII and Shortening of the Prothrombin Time.- Immunologic Aspects of Vessel Injury and Thrombosis.- What's The Dose?.- Venous Thromboembolism - Primary Prophylaxis.- Venous Thromboembolism in Moderate Risk Patients.- Two-Step Warfarin Therapy for the Prophylaxis of Venous Thrombosis after Elective Surgery.- Prevention of Venous Thromboembolism in High-Risk Patients by Prophylactic Administration of Oral Anticoagulants.- Genetic Coagulation Defects.- Venous Thromboembolism - Secondary Prophylaxis.- Treatment of First Episode of Venous Thrombosis.- Management of Recurrent Venous Thromboembolism.- Special Issues.- Warfarin Metabolism and Drug-Drug Interactions.- Improving the Benefit/Risk Ratio.- Oral Anticoagulant Therapy and Skin Necrosis: Speculations on Pathogenesis.- Cardiovascular - Arterial Thromboembolism.- Clinical Trials in Myocardial Infarction and Coronary Heart Disease.- Anticoagulants in Acute Myocardial Infarction.- Long-Term Anticoagulant Treatment after Acute Myocardial Infarction.- Following Coronary Thrombolysis.- Arterial Thromboembolism: Valvular Heart Disease and Prosthetic Heart Valves.- Neurovascular - Arterial Thromboembolism.- Clinical Trial Dilemmas and Cerebrovascular Disease.- Atrial Fibrillation and Stroke: The View from Cardiology.- Atrial Fibrillation and Stroke: The View from Neurology.- Cardiac Embolic Stroke: Anticoagulating the Elderly.- Anticoagulants for the Treatment of Transient Ischemic Attacks.- Epilogue.- Contributors.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Thrombolytic therapy -- Congresses.
موضوع مستند نشده
Thrombosis -- Prevention -- Congresses.
موضوع مستند نشده
Warfarin -- Congresses.
رده بندی کنگره
شماره رده
RC694
.
3
نشانه اثر
E358
1987
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )
مستند نام اشخاص تاييد نشده
edited by Stanford Wessler, Carl G. Becker, and Yale Nemerson.